Home » Stocks » INNT

Innovate Biopharmaceuticals, Inc. (INNT)

May 4, 2020 - INNT merged into NMTR
Stock Price: $0.560 USD 0.000 (0.00%)
Updated May 1, 2020 4:00 PM EDT
Market Cap 23.14M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 41.33M
EPS (ttm) -0.71
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 1, 2020
Last Price $0.560
Previous Close $0.560
Change ($) 0.000
Change (%) 0.00%
Day's Open -
Day's Range 0.551 - 0.720
Day's Volume 1,547,785
52-Week Range 0.370 - 1.670

News

Hide News
Seeking Alpha - 1 year ago

Innovate Biopharmaceuticals, Inc. (INNT) CEO Sandeep Laumas on Q1 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Innovate Biopharmaceuticals, Inc. (INNT) CEO Sandeep Laumas on Q4 2018 Results - Earnings Call Transcript

About INNT

9 Meters Biopharma operates as a rare, orphan, and unmet needs-focused GI company. The company is advancing its drug candidates for short bowel syndrome and celiac disease. Its product candidates include NM-002, a proprietary long-acting GLP-1 agonist into Phase 2 trial for short bowel syndrome; and larazotide, a Phase 3 tight junction regulator being evaluated for patient-reported symptom improvement in non-responsive celiac disease. The company's pipeline products also includes NM-004, an oral gut restricted immunomodulator and NM-003, a long... [Read more...]

Industry
Biotechnology
Founded
2012
CEO
Sandeep Laumas
Employees
8
Stock Exchange
NASDAQ
Ticker Symbol
INNT
Full Company Profile